Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 71

1.

Sirolimus-induced bronchiolitis obliterans organizing pneumonia in a kidney transplant recipient; a case report and review of literature.

Einollahi B, Aslani J, Taghipour M, Motalebi M, Karimi-Sari H.

J Nephropathol. 2014 Jul;3(3):109-13. doi: 10.12860/jnp.2014.21. Epub 2014 Jul 1.

2.

Interstitial pneumonitis caused by everolimus: a case-cohort study in renal transplant recipients.

Baas MC, Struijk GH, Moes DJ, van den Berk IA, Jonkers RE, de Fijter JW, van der Heide JJ, van Dijk M, ten Berge IJ, Bemelman FJ.

Transpl Int. 2014 May;27(5):428-36. doi: 10.1111/tri.12275. Epub 2014 Mar 5.

PMID:
24484452
3.

How often do we face side effects of sirolimus in pediatric renal transplantation?

Fidan K, Kandur Y, Sozen H, Gonul II, Dalgic A, Söylemezoğlu O.

Transplant Proc. 2013 Jan-Feb;45(1):185-9. doi: 10.1016/j.transproceed.2012.08.005.

PMID:
23375296
4.

Early everolimus-induced pneumonitis in a renal transplant recipient: A case report.

Sułkowska K, Palczewski P, Miszewska-Szyszkowska D, Durlik M, Gołębiowski M, Małkowski P.

Ann Transplant. 2012 Dec 31;17(4):144-8.

PMID:
23274336
5.

Sirolimus therapy may cause cardiac tamponade.

Bertrand D, Desbuissons G, Pallet N, Debure A, Sartorius A, Anglicheau D, Mamzer MF, Legendre C, Sberro-Soussan R.

Transpl Int. 2013 Feb;26(2):e4-7. doi: 10.1111/tri.12025. Epub 2012 Nov 29.

PMID:
23189945
6.

The metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation.

Rangel EB.

Expert Opin Drug Metab Toxicol. 2012 Dec;8(12):1531-48. doi: 10.1517/17425255.2012.724058. Epub 2012 Sep 17. Review.

PMID:
22978385
7.

Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens.

Kirby S, Satoskar A, Brodsky S, Pope-Harman A, Nunley D, Hitchcock C, Pelletier R, Ross P, Nadasdy T, Shilo K.

Diagn Pathol. 2012 Mar 14;7:25. doi: 10.1186/1746-1596-7-25.

8.

[Conversion from calcineurin inhibitors to sirolimus in chronic allograft nephropathy: a 4-year prospective study].

Huang HF, Wu JY, Han F, Wang YM, Zhang JG, Chen JH.

Zhonghua Yi Xue Za Zhi. 2011 Dec 27;91(48):3397-400. Chinese.

PMID:
22333250
9.

Pulmonary embolism and reactivation of tuberculosis during everolimus therapy in a kidney transplant recipient.

Fijałkowska-Morawska JB, Jagodzińska M, Nowicki M.

Ann Transplant. 2011 Oct-Dec;16(4):107-10.

PMID:
22210429
10.

Sirolimus in pediatric renal transplantation.

Kasap B.

Pediatr Transplant. 2011 Nov;15(7):673-85. doi: 10.1111/j.1399-3046.2011.01575.x. Review.

PMID:
22004542
11.

Subclinical interstitial lung abnormalities in stable renal allograft recipients in the era of modern immunosuppression.

Bertolini L, Vaglio A, Bignardi L, Buzio C, De Filippo M, Palmisano A, Mercati K, Zompatori M, Maggiore U.

Transplant Proc. 2011 Sep;43(7):2617-23. doi: 10.1016/j.transproceed.2011.06.033.

PMID:
21911134
12.

An international expanded-access programme of everolimus: addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy.

Grünwald V, Karakiewicz PI, Bavbek SE, Miller K, Machiels JP, Lee SH, Larkin J, Bono P, Rha SY, Castellano D, Blank CU, Knox JJ, Hawkins R, Anak O, Rosamilia M, Booth J, Pirotta N, Bodrogi I; REACT Study Group.

Eur J Cancer. 2012 Feb;48(3):324-32. doi: 10.1016/j.ejca.2011.06.054. Epub 2011 Jul 29.

PMID:
21803569
13.

Calcineurin inhibitor-free immunosuppression using everolimus (Certican) after heart transplantation: 2 years' follow-up from the University Hospital Münster.

Stypmann J, Engelen MA, Eckernkemper S, Amler S, Gunia S, Sindermann JR, Rothenburger M, Rukosujew A, Drees G, Welp HA.

Transplant Proc. 2011 Jun;43(5):1847-52. doi: 10.1016/j.transproceed.2010.12.062.

PMID:
21693288
14.

Conversion from cyclosporine to sirolimus in chronic renal allograft dysfunction: a 4-year prospective study.

Han F, Wu J, Huang H, Zhang X, He Q, Wang Y, Wang S, Wang H, Chen J.

Exp Clin Transplant. 2011 Feb;9(1):42-9.

PMID:
21605022
15.

Erythema nodosum in kidney transplant recipient: a rare complication of pneumonia treatment.

Gregorini M, Castello M, Rampino T, Esposito P, Rosso R, Borroni G, Dal Canton A.

Transpl Infect Dis. 2012 Feb;14(1):72-4. doi: 10.1111/j.1399-3062.2011.00635.x. Epub 2011 Apr 5.

PMID:
21466642
16.

Diagnostic utility of flexible bronchoscopy in recipients of solid organ transplants.

Kupeli E, Akcay S, Ulubay G, Ozyurek BA, Ozdemirel TS, Haberal M.

Transplant Proc. 2011 Mar;43(2):543-6. doi: 10.1016/j.transproceed.2011.01.015.

PMID:
21440756
17.

Two-year outcomes in thoracic transplant recipients after conversion to everolimus with reduced calcineurin inhibitor within a multicenter, open-label, randomized trial.

Gullestad L, Mortensen SA, Eiskjær H, Riise GC, Mared L, Bjørtuft O, Ekmehag B, Jansson K, Simonsen S, Gude E, Rundqvist B, Fagertun HE, Solbu D, Iversen M.

Transplantation. 2010 Dec 27;90(12):1581-9. doi: 10.1097/TP.0b013e3181fd01b7.

PMID:
21030905
18.

Pneumonitis associated with mammalian target of rapamycin inhibitors in renal transplant recipients: a single-center experience.

Errasti P, Izquierdo D, Martín P, Errasti M, Slon F, Romero A, Lavilla FJ.

Transplant Proc. 2010 Oct;42(8):3053-4. doi: 10.1016/j.transproceed.2010.07.066.

PMID:
20970608
19.

Sirolimus for calcineurin inhibitors in organ transplantation: contra.

Cravedi P, Ruggenenti P, Remuzzi G.

Kidney Int. 2010 Dec;78(11):1068-74. doi: 10.1038/ki.2010.268. Epub 2010 Aug 11. Review.

PMID:
20703217
20.

Immunosuppressive therapy and infection after kidney transplantation.

Fortun J, Martin-Davila P, Pascual J, Cervera C, Moreno A, Gavalda J, Aguado JM, Pereira P, Gurguí M, Carratala J, Fogueda M, Montejo M, Blasco F, Bou G, Torre-Cisneros J; RESITRA Transplant Network.

Transpl Infect Dis. 2010 Oct;12(5):397-405. doi: 10.1111/j.1399-3062.2010.00526.x.

PMID:
20553437
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk